These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 11605784)

  • 1. Abnormal DNA-binding of transcription factors in minimal change nephrotic syndrome.
    Cao C; Lu S; Dong C; Zhao R
    Pediatr Nephrol; 2001 Oct; 16(10):790-5. PubMed ID: 11605784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abnormal glucocorticoid receptor-activator protein 1 interaction in steroid-resistant asthma.
    Adcock IM; Lane SJ; Brown CR; Lee TH; Barnes PJ
    J Exp Med; 1995 Dec; 182(6):1951-8. PubMed ID: 7500041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hsp90 inhibitors attenuate effect of dexamethasone on activated NF-kappaB and AP-1.
    Tago K; Tsukahara F; Naruse M; Yoshioka T; Takano K
    Life Sci; 2004 Mar; 74(16):1981-92. PubMed ID: 14967193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of glucocorticoids on transcription factor activation in human peripheral blood mononuclear cells.
    Adcock IM; Brown CR; Gelder CM; Shirasaki H; Peters MJ; Barnes PJ
    Am J Physiol; 1995 Feb; 268(2 Pt 1):C331-8. PubMed ID: 7864072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered glucocorticoid receptor signaling cascade in lymphocytes of bipolar disorder patients.
    Spiliotaki M; Salpeas V; Malitas P; Alevizos V; Moutsatsou P
    Psychoneuroendocrinology; 2006 Jul; 31(6):748-60. PubMed ID: 16621324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucocorticoid receptor signaling in a bronchial epithelial cell line.
    LeVan TD; Behr FD; Adkins KK; Miesfeld RL; Bloom JW
    Am J Physiol; 1997 May; 272(5 Pt 1):L838-43. PubMed ID: 9176246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of endogenous glucocorticoid repressed genes differentially regulated by a glucocorticoid receptor mutant able to separate between nuclear factor-kappaB and activator protein-1 repression.
    Bladh LG; Lidén J; Dahlman-Wright K; Reimers M; Nilsson S; Okret S
    Mol Pharmacol; 2005 Mar; 67(3):815-26. PubMed ID: 15550679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucocorticoid receptor, nuclear factor kappaB, activator protein-1 and C-jun N-terminal kinase in systemic lupus erythematosus patients.
    Oikonomidou O; Vlachoyiannopoulos PG; Kominakis A; Kalofoutis A; Moutsopoulos HM; Moutsatsou P
    Neuroimmunomodulation; 2006; 13(4):194-204. PubMed ID: 17347585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitors of both nuclear factor-kappaB and activator protein-1 activation block the neoplastic transformation response.
    Li JJ; Westergaard C; Ghosh P; Colburn NH
    Cancer Res; 1997 Aug; 57(16):3569-76. PubMed ID: 9270030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucocorticoid-mediated suppression of cytokine-induced matrix metalloproteinase-9 expression in rat mesangial cells: involvement of nuclear factor-kappaB and Ets transcription factors.
    Eberhardt W; Schulze M; Engels C; Klasmeier E; Pfeilschifter J
    Mol Endocrinol; 2002 Aug; 16(8):1752-66. PubMed ID: 12145332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcriptional and post-transcriptional alterations of IkappaBalpha in active minimal-change nephrotic syndrome.
    Sahali D; Pawlak A; Gouvello SL; Lang P; Valanciuté A; Remy P; Loirat C; Niaudet P; Bensman A; Guellaen G
    J Am Soc Nephrol; 2001 Aug; 12(8):1648-1658. PubMed ID: 11461937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased expression of T-cell NF-kappaB p65 subunit in steroid-resistant nephrotic syndrome.
    Aviles DH; Matti Vehaskari V; Manning J; Ochoa AC; Zea AH
    Kidney Int; 2004 Jul; 66(1):60-7. PubMed ID: 15200413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of granulocyte-macrophage colony-stimulating factor expression by glucocorticoids involves inhibition of enhancer function by the glucocorticoid receptor binding to composite NF-AT/activator protein-1 elements.
    Smith PJ; Cousins DJ; Jee YK; Staynov DZ; Lee TH; Lavender P
    J Immunol; 2001 Sep; 167(5):2502-10. PubMed ID: 11509589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of activity of nuclear factor-kappaB and activator protein-1 by nitric oxide, surfactant and glucocorticoids in alveolar macrophages from piglets with acute lung injury.
    Cao L; Qian LL; Zhu YR; Guo CB; Gong XH; Sun B
    Acta Pharmacol Sin; 2003 Dec; 24(12):1316-23. PubMed ID: 14653966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The transcription factors NF-kappab and AP-1 are differentially regulated in skeletal muscle during sepsis.
    Penner CG; Gang G; Wray C; Fischer JE; Hasselgren PO
    Biochem Biophys Res Commun; 2001 Mar; 281(5):1331-6. PubMed ID: 11243882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of glucocorticoids on phorbol ester and cytokine stimulated transcription factor activation in human lung.
    Adcock IM; Shirasaki H; Gelder CM; Peters MJ; Brown CR; Barnes PJ
    Life Sci; 1994; 55(14):1147-53. PubMed ID: 8090056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The balance between expression of intranuclear NF-kappaB and glucocorticoid receptor in polymorphonuclear leukocytes in SIRS patients.
    Nakamori Y; Ogura H; Koh T; Fujita K; Tanaka H; Sumi Y; Hosotsubo H; Yoshiya K; Irisawa T; Kuwagata Y; Shimazu T; Sugimoto H
    J Trauma; 2005 Aug; 59(2):308-14; discussion 314-5. PubMed ID: 16294069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of dexamethasone on binding activity of transcription factors nuclear factor-kappaB and activator protein-1 in SW982 human synovial sarcoma cells.
    Yamazaki T; Tukiyama T; Tokiwa T
    In Vitro Cell Dev Biol Anim; 2005; 41(3-4):80-2. PubMed ID: 16029077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transforming growth factor-beta 1 increases glucocorticoid binding and signaling in macrophages through a Smad- and activated protein-1-mediated process.
    Peltier J; Perez J; Bellocq A; Escoubet B; Fouqueray B; Baud L
    Kidney Int; 2003 Jun; 63(6):2028-36. PubMed ID: 12753290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Negative cross-talk between RelA and the glucocorticoid receptor: a possible mechanism for the antiinflammatory action of glucocorticoids.
    Caldenhoven E; Liden J; Wissink S; Van de Stolpe A; Raaijmakers J; Koenderman L; Okret S; Gustafsson JA; Van der Saag PT
    Mol Endocrinol; 1995 Apr; 9(4):401-12. PubMed ID: 7659084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.